Laura Broutier

Lyon, 69008, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids.

Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids.

Journal: Journal of medicinal chemistry

Published: July 08, 2026

Dysregulation of human ClpP using small molecules with piperazine-based scaffold for diffuse intrinsic pontine glioma therapy validated by patient-derived tumor organoids.

Dysregulation of human ClpP using small molecules with piperazine-based scaffold for diffuse intrinsic pontine glioma therapy validated by patient-derived tumor organoids.

Journal: Research square

Published: February 06, 2026

Multiscale modeling of the spatial structure of stem cells in neuroblastoma patient-derived tumoroids reveals a critical role for a short-range diffusive process.

Multiscale modeling of the spatial structure of stem cells in neuroblastoma patient-derived tumoroids reveals a critical role for a short-range diffusive process.

Journal: PLoS computational biology

Published: August 19, 2025

Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology.

Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology.

Journal: Neuro-oncology

Published: January 10, 2025

BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas.

BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas.

Journal: eLife

Published: October 07, 2024

Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers.

Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers.

Journal: Cell reports. Medicine

Published: April 13, 2023

The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas.

The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas.

Journal: Cell death discovery

Published: February 23, 2023

Staining and High-Resolution Imaging of Three-Dimensional Organoid and Spheroid Models.

Staining and High-Resolution Imaging of Three-Dimensional Organoid and Spheroid Models.

Journal: Journal of visualized experiments : JoVE

Published: April 12, 2021

Future Match Making: When Pediatric Oncology Meets Organoid Technology.

Future Match Making: When Pediatric Oncology Meets Organoid Technology.

Journal: Frontiers in cell and developmental biology

Published: February 28, 2021

Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling.

Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling.

Journal: Cell death & disease

Published: January 25, 2020

Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling.

Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling.

Journal: Cell death & disease

Published: June 03, 2019

Targeting netrin-1/DCC interaction in diffuse large B-cell and mantle cell lymphomas.

Targeting netrin-1/DCC interaction in diffuse large B-cell and mantle cell lymphomas.

Journal: EMBO molecular medicine

Published: February 17, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026